According to the latest report by IMARC Group, titled “Bioburden Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global bioburden testing market size exhibited strong growth during 2015-2020.Looking forward, IMARC Group expects the global bioburden testing market to grow at a CAGR of around 12% during the forecast period (2021-2026). Bioburden testing helps in measuring the total viable count of microbial contamination in a product. It is extensively used in the pharmaceutical industry to analyze and understand the different types and amounts of microorganisms in sterile medical devices throughout the production process. Before the test, a suitability experiment is usually carried out to ensure the effectiveness of the testing method while recovering the microorganisms present on the device.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/bioburden-testing-market/requestsample
At present, the government authorities of several countries are implementing stringent policies and regulations to validate the sterilization process of medical devices. This represents one of the primary factors escalating the demand for bioburden testing. Furthermore, the growing utilization of single-use medical items is also providing a thrust to the global market. Moreover, as bioburden testing is an essential part of the microbiological monitoring program while manufacturing sterile products, it is gaining traction in the cosmetics sector for maintaining the overall safety and performance of the packaged goods. Besides this, a rapid increase in coronavirus cases is augmenting the need for bioburden reduction systems that utilize dry heat to support the reuse of particulate filtering facepiece respirators (FFRs). All of these above-mentioned factors will continue to drive the global market for bioburden testing in the coming years.
Explore Full Report with TOC & List of Figure:https://www.imarcgroup.com/bioburden-testing-market
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Becton Dickinson and Company
- Biomérieux SA (Compagnie Merieux Alliance)
- Charles River Laboratories Inc
- Merck KGaA
- Nelson Laboratories LLC (Sotera Health LLC)
- North American Science Associates Inc.
- Pacific BioLabs Inc.
- SGS SA
- Thermo Fisher Scientific Inc
- Wuxi Apptec
Breakup by Product:
- Culture Media
- Automated Microbial Identification Systems
- Polymerase Chain Reaction Systems
Breakup by Test Type:
- Aerobic Count Testing
- Anaerobic Count Testing
- Fungi/Mold Count Testing
- Spores Count Testing
Breakup by Application:
- Raw Material Testing
- Medical Devices Testing
- In-process Testing
- Sterilization Validation Testing
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Contract Manufacturing Organizations (CMOs)
- Food and Beverages Companies
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Key highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal